OTTEN; Gillis

Patent Applications and Registrations

Patent applications and USPTO patent grants for OTTEN; Gillis.The latest application filed is for "adjuvanted multivalent influenza vaccines".

Company Profile

4.15.22

OTTEN; Gillis - Cambridge MA
Otten; Gillis - Rowley MA
Otten; Gillis - Foster City CA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Adjuvanted Multivalent Influenza Vaccines App 20220168413 - CIARLET; Max ; et al.	2022-06-02
Delivery of RNA to trigger multiple immune pathways Grant 11,324,770 - Geall , et al. May 10, 2	2022-05-10
Delivery of RNA to trigger multiple immune pathways Grant 11,291,682 - Geall , et al. April 5, 2	2022-04-05
Delivery Of Rna To Trigger Multiple Immune Pathways App 20220054525 - GEALL; Andrew ; et al.	2022-02-24
Immunogenic Compositions And Uses Thereof App 20210290755 - GEALL; Andrew ; et al.	2021-09-23
Delivery Of Rna To Different Cell Types App 20210268013 - GEALL; Andrew ; et al.	2021-09-02
Immunogenic compositions and uses thereof Grant 11,058,762 - Geall , et al. July 13, 2	2021-07-13
Delivery of RNA to different cell types Grant 11,026,964 - Geall , et al. June 8, 2	2021-06-08
Delivery Of Rna To Trigger Multiple Immune Pathways App 20200323896 - GEALL; Andrew ; et al.	2020-10-15
Delivery of RNA to trigger multiple immune pathways Grant 10,532,067 - Geall , et al. Ja	2020-01-14
Delivery Of Rna To Trigger Multiple Immune Pathways App 20190343862 - Geall; Andrew ; et al.	2019-11-14
Benzonapthyridine Compositions And Uses Thereof App 20180333406 - OTTEN; Gillis ; et al.	2018-11-22
Delivery Of Rna To Trigger Multiple Immune Pathways App 20180085388 - Geall; Andrew ; et al.	2018-03-29
Delivery Of Rna To Different Cell Types App 20180050059 - Geall; Andrew ; et al.	2018-02-22
Delivery of RNA to trigger multiple immune pathways Grant 9,801,897 - Geall , et al. October 31, 2	2017-10-31
Delivery of RNA to different cell types Grant 9,770,463 - Geall , et al. September 26, 2	2017-09-26
Benzonapthyridine compositions and uses thereof Grant 9,597,326 - Otten , et al. March 21, 2	2017-03-21
Immunogenic Compositions And Uses Thereof App 20150140068 - Barnett; Susan ; et al.	2015-05-21
Immunogenic Compositions And Uses Thereof App 20140242152 - Geall; Andrew ; et al.	2014-08-28
Compositions and methods for generating an immune response utilizing alphavirus-based vector systems Grant 8,647,864 - Polo , et al. February 11, 2	2014-02-11
Delivery Of Rna To Different Cell Types App 20130177640 - Geall; Andrew ; et al.	2013-07-11
Delivery Of Rna To Trigger Multiple Immune Pathways App 20130177639 - Geall; Andrew ; et al.	2013-07-11
Benzonapthyridine Compositions And Uses Thereof App 20130122042 - Otten; Gillis ; et al.	2013-05-16
Compositions and Methods for Generating an Immune Response Utilizing Alphavirus-Based Vector Systems App 20100266631 - Polo; John ; et al.	2010-10-21
Compositions and methods for generating an immune response utilizing alphavirus-based vector systems Grant 7,771,979 - Polo , et al. August 10, 2	2010-08-10
Compositions and methods for generating an immune response utilizing alphavirus-based vector systems App 20080226598 - Polo; John ; et al.	2008-09-18
Microparticles for delivery of heterologous nucleic acids App 20080026071 - O'Hagan; Derek ; et al.	2008-01-31
Microparticles for delivery of heterologous nucleic acids App 20030138453 - O'Hagan, Derek ; et al.	2003-07-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.